HIF1A and neoplasm: Notably, copper chelator treatment alone was not sufficient to fully deplete copper in tumour cells, possibly due to compensatory mechanisms such as transporter protein plasticity (CTR1/ATP7A, etc.)and HIF-1α-mediated glycolytic metabolic reprogramming (78, 93, 94).